Arabian Gulf University, Manama, Bahrain.
Rashid Hospital, Dubai, United Arab Emirates.
J Infect Public Health. 2021 Jul;14(7):978-984. doi: 10.1016/j.jiph.2021.04.009. Epub 2021 Apr 24.
Antimicrobial resistance is a significant global issue that presents an increasing threat to patients' wellbeing. Although a global concern, the emergence of multi-drug resistant organisms is of particular significance in the Middle East. In recent years, this region has seen an alarming increase in antimicrobial resistance presenting a major challenge to physicians managing various infectious diseases.
A Working Group comprising experts in infectious diseases from Arab countries of Middle East assembled to review similarities and differences in antimicrobial practices and management of multi-drug resistant organisms across the region and assess the barriers to achieving cross-regional collaboration. The Working Group conducted an anonymous online survey to evaluate current practice and understanding of management of multi-drug resistant organisms across the region.
A total of 122 physicians from Arab countries of the Middle East responded to the survey. Their responses demonstrated heterogeneity between countries in awareness of local epidemiology, management of multi-drug resistant organisms and antimicrobial stewardship practices. The Working Group recognized similarities and differences in the management of multi-drug resistant organisms across the region, and these were validated by the data collected in the survey. Overall, the similarities across the region reflect several key issues that can have an impact on the management of multi-drug resistant organisms and the prevention of antimicrobial resistance.
This paper highlights the urgency of addressing antimicrobial resistance in Arab countries of the Middle East. The Working Group identified key barriers to effective management which may guide the development of future coherent strategies to promote effective antimicrobial stewardship in the region. Here, we outline a call to action for the region, with a need to focus on training and education, capacity building, infrastructure, regional research, and regional surveillance.
抗菌药物耐药性是一个全球性的重大问题,对患者的健康构成了日益严重的威胁。尽管这是一个全球性的问题,但多药耐药菌的出现尤其在中东地区具有重要意义。近年来,该地区对抗菌药物耐药性的出现感到震惊,这对管理各种传染病的医生构成了重大挑战。
一个由来自中东阿拉伯国家的传染病专家组成的工作组,对该地区抗菌药物实践和多药耐药菌管理方面的相似性和差异进行了回顾,并评估了实现跨区域合作的障碍。该工作组进行了一项匿名在线调查,以评估该地区当前对多药耐药菌管理的实践和理解。
来自中东阿拉伯国家的 122 名医生对该调查做出了回应。他们的回答表明,各国对当地流行病学、多药耐药菌管理和抗菌药物管理实践的认识存在差异。工作组认识到该地区多药耐药菌管理方面的异同,并通过调查收集的数据验证了这些异同。总的来说,该地区的相似性反映了几个可能影响多药耐药菌管理和抗菌药物耐药性预防的关键问题。
本文强调了在中东阿拉伯国家解决抗菌药物耐药性问题的紧迫性。工作组确定了有效管理的关键障碍,这些障碍可能指导制定未来的连贯战略,以促进该地区有效的抗菌药物管理。在这里,我们概述了该地区的行动呼吁,需要关注培训和教育、能力建设、基础设施、区域研究和区域监测。